DOPATREE
Preview
Open in TheBrain
DOPATREE
ORGANIZATIONS
COMPANIES-ALL (COMPANY, CLIENTS, SPONSORS, SMALL, MID-SIZE, LARGE PHARMA, BIG PHARMA, BIOPHARMA, EMERGING COMPANIES, STARTUPS, START-UPS, SPIN-OFFS, SUBSIDIARIES, SUBSIDIARY, BIOTECHNOLOGY, EMERGING)
COMPANIES / LISTINGS-N
NOVARTIS
NOVARTIS / RELATED
ADVANCED ACCELERATOR APPLICATIONS (AAA)
ADVANCED ACCELERATOR APPLICATIONS / PROUCTS / APPROVED
LUTATHERA® (LUTETIUM LU 177)
LUTATHERA / WARNINGS AND PRECAUTIONS
Parents
LUTATHERA® (LUTETIUM LU 177)
Children
BONE MARROW SUPPRESSION (MYELOSUPPRESSION, MYELOTOXICITY, PANCYTOPENIA, MYELOABLATION)
EMBRYOFETAL TOXICITY (EMBRYONIC DEVELOPMENT, STUDIES, DEVELOPMENTAL TOXICITY, EMBRYO-FETAL, REPRODUCTIVE TOXICITY, TERATOGENICITY, RISK OF DRUG EXPOSURE DURING PREGNANCY)
HEPATOTOXICITY (DRUG-INDUCED LIVER INJURY, DILI, HEPATIC TOXICITY, LIVER TOXICITY, DRUG INDUCED)
INFERTILITY (INFERTILE, FERTILITY PROBLEMS, REPRODUCTIVE, IMPAIRED FECUNDITY, NOT FERTILE, UNABLE TO CONCEIVE)
IONIZING RADIATION (RADIOACTIVITY, RADIOACTIVE EXPOSURE, CAS# : HZ1800-45-T)
LEUKEMIA-ALL (CHILDHOOD, PEDIATRIC, GENERAL LEUKAEMIA)
MYELODYSPLASTIC SYNDROME (MDS, MYELODYSPLASIA, PRE-LEUKEMIA, REFRACTORY ANEMIA)
NEPHROTOXICITY (RENAL TOXICITY, DRUG-INDUCED)
NEUROENDOCRINE HORMONAL CRISIS